The reason why Eg5 inhibitor exhibited significant anticancer efficacy in gemcitabine resistant bladder cancer cell lines may be because Eg5 and RRM exist gene coexpression in bladder cancer, and we will study the relationship in the following research. This evidence concerns the gene KIF11 and urinary bladder carcinoma.